Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis;Recomendaciones para el uso de metotrexato en pacientes con artritis idiopática juvenil

Anales de Pediatria

Volumn 84, Issue 3, 2016, Pages 177e1-177e8

  Calvo, I ^a   Anton J ^b   Lopez Robledillo J C ^c   De Inocencio, J ^d   Gamir, M L ^e   Merino, R ^f   Lacruz, L ^g   Camacho, M ^h   Rua, M J ⁱ   Bustabad, S ^j   Diaz Cordoves Rego G ^k  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^k UNIVERSITY OF MÁLAGA   (Spain)

more..

Author keywords

Consensus; Juvenile idiopathicarthritis; Methotrexate

Indexed keywords

FOLIC ACID; FOLINIC ACID; LIVER ENZYME; METHOTREXATE;

ANALYTICAL PARAMETERS; BLOOD CELL COUNT; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG BIOAVAILABILITY; DRUG TOLERABILITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE; POLYARTHRITIS; REMISSION; RISK FACTOR; SYSTEMATIC REVIEW; UVEITIS; ARTHRITIS; ARTHRITIS, JUVENILE;

ARTHRITIS; ARTHRITIS, JUVENILE; BLOOD CELL COUNT; HUMANS; METHOTREXATE; REMISSION INDUCTION; RISK FACTORS; UVEITIS;

EID: 84959356647     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2015.05.005     Document Type: Conference Paper

References (40)

1. R.E. Petty, T.R. Southwood, P. Manners, J. Baum, D.N. Glass, J. Goldenberg, and et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001 J Rheumatol 31 2004 390 392
2. G. Dueckers, N. Guellac, M. Arbogast, G. Dannecker, I. Foeldvari, M. Frosch, and et al. Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis Clin Immunol 142 2012 176 193
3. M.W. Beresford Juvenile idiopathic arthritis: New insights into classification, measures of outcome, and pharmacotherapy Paediatric Drugs 13 2011 161 173
4. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer's handbook. Edinburgh: SIGN; 2014. (SIGN publication no. 50). [October 2014]. Available from URL: http://www.sign.ac.uk
5. W. Feldman Evidence-based Pediatrics 1st ed 2000 Hamilton BC Deckers
6. Oxford Centre for Evidence-Based Medicine. Levels of evidence. 2009 [consultado 9 Oct 2014]. Disponible en: http://www.cebm.net/oxford-centre-evidence-based-medicinelevels-evidence-march-2009/
7. T. Beukelman, N.M. Patkar, K.G. Saag, S. Tolleson-Rinehart, R.Q. Cron, E.M. DeWitt, and et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features Arthritis Care Res (Hoboken) 63 2011 465 482
8. T. Niehues, G. Horneff, H. Michels, M.S. Hock, L. Schuchmann Working Groups Pediatric Rheumatology Evidence-based use of methotrexate in children with rheumatic diseases: A consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria Rheumatol Int 25 2005 169 178
9. K. Visser, and D.M. van der Heijde Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: A systematic review of the literature Clin Exp Rheumatol 27 2009 1017 1025
10. N. Ruperto, K.J. Murray, V. Gerloni, N. Wulffraat, S.K. de Oliveira, F. Falcini, and et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate Arthritis Rheum 50 2004 2191 2201
11. A. Cespedes-Cruz, R. Gutierrez-Suarez, A. Pistorio, A. Ravelli, A. Loy, K.J. Murray, and et al. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis Ann Rheum Dis 67 2008 309 314
12. J.S. Gao, H. Wu, and J. Tian [Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate] Zhonghua Er Ke Za Zhi 41 2003 435 438
13. N. Ruperto, D.J. Lovell, R. Cuttica, N. Wilkinson, P. Woo, G. Espada, and et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis Arthritis Rheum 56 2007 3096 3106
14. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group J Rheumatol 22 1995 218 223
15. R. Bou, A. Adan, F. Borras, B. Bravo, I. Calvo, J. de Inocencio, and et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: Interdisciplinary panel consensus Rheumatol Int 35 2015 777 778
16. E.H. Giannini, E.J. Brewer, N. Kuzmina, A. Shaikov, A. Maximov, I. Vorontsov, and et al. Methotrexate in resistant juvenile rheumatoid arthritis Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group N Engl J Med 326 1992 1043 1049
17. C. Papadopoulou, M. Kostik, M. Bohm, J.C. Nieto-Gonzalez, M.I. Gonzalez-Fernandez, A. Pistorio, and et al. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis J Pediatr 163 2013 879 884
18. G. Simonini, P. Paudyal, G.T. Jones, R. Cimaz, and G.J. Macfarlane Current evidence of methotrexate efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach Rheumatology (Oxford) 52 2013 825 831
19. F.M. Balis, J. Mirro Jr., G.H. Reaman, W.E. Evans, C. McCully, K.M. Doherty, and et al. Pharmacokinetics of subcutaneous methotrexate J Clin Oncol 6 1988 1882 1886
20. F.M. Balis, J.L. Savitch, and W.A. Bleyer Pharmacokinetics of oral methotrexate in children Cancer Res 43 1983 2342 2345
21. D. Oguey, F. Kolliker, N.J. Gerber, and J. Reichen Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 35 1992 611 614
22. C.A. Wallace The use of methotrexate in childhood rheumatic diseases Arthritis Rheum 41 1998 381 391
23. R. Hasija, A. Pistorio, A. Ravelli, E. Demirkaya, R. Khubchandani, D. Guseinova, and et al. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study Arthritis Rheum 63 2011 3142 3152
24. Ficha técnica de Metoject. [consultado 3 Abr 2013]. Disponible en: http://www.aemps.gob.es/cima/especialidad.do?metodo=verFichaWordPdf&codigo=71109&formato=pdf&formulario=FICHAS
25. M.W. Heijstek, L.M. Ott de Bruin, M. Bijl, R. Borrow, F. van der Klis, I. Kone-Paut, and et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases Ann Rheum Dis 70 2011 1704 1712
26. O. Ortiz-Alvarez, K. Morishita, G. Avery, J. Green, R.E. Petty, L.B. Tucker, and et al. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis J Rheumatol 31 2004 2501 2506
27. L. Kocharla, J. Taylor, T. Weiler, T.V. Ting, M. Luggen, and H.I. Brunner Monitoring methotrexate toxicity in juvenile idiopathic arthritis J Rheumatol 36 2009 2813 2818
28. P. Lahdenne, J. Rapola, H. Ylijoki, and J. Haapasaari Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy J Rheumatol 29 2002 2442 2445
29. P.J. Hashkes, W.F. Balistreri, K.E. Bove, E.T. Ballard, and M.H. Passo The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis J Pediatr 134 1999 47 52
30. C.A. Wallace, W.A. Bleyer, D.D. Sherry, K.L. Salmonson, and R.J. Wedgwood Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis Arthritis Rheum 32 1989 677 681
31. H.M. Albers, J.A. Wessels, R.J. van der Straaten, D.M. Brinkman, L.W. Suijlekom-Smit, S.S. Kamphuis, and et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis Arthritis Rheum 61 2009 46 51
32. K. Alsufyani, O. Ortiz-Alvarez, D.A. Cabral, L.B. Tucker, R.E. Petty, and P.N. Malleson The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate J Rheumatol 31 2004 179 182
33. M. Kosmac, N. Toplak, G. Simonini, I. Pagnini, R. Cimaz, V.C. Serbec, and et al. Anti-drug antibodies are associated with diminished drug levels and treatment failure (abstract) Arthritis Rheum 64 Suppl 10 2012 2598
34. S. Murias, R. Alcobendas, D. Pascual-Salcedo, A. Remesal, J. Peralta, and R. Merino Anti-adalimumab antibodies in paediatric rheumatology patients: A pilot experience Rheumatology (Oxford) 53 2014 2124 2126
35. C.L. Krieckaert, M.T. Nurmohamed, and G.J. Wolbink Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner Ann Rheum Dis 71 2012 1914 1915
36. D.J. Lovell, N. Ruperto, S. Goodman, A. Reiff, L. Jung, K. Jarosova, and et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis N Engl J Med 359 2008 810 820
37. S. Pavy, A. Constantin, T. Pham, L. Gossec, J.F. Maillefert, A. Cantagrel, and et al. Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion Joint Bone Spine 73 2006 388 395
38. A. Consolaro, N. Ruperto, A. Bazso, A. Pistorio, S. Magni-Manzoni, G. Filocamo, and et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis Arthritis Rheum 61 2009 658 666
39. G. Filocamo, A. Consolaro, B. Schiappapietra, S. Dalpra, B. Lattanzi, S. Magni-Manzoni, and et al. A new approach to clinical care of juvenile idiopathic arthritis: The Juvenile Arthritis Multidimensional Assessment Report J Rheumatol 38 2011 938 953
40. J. De Inocencio, J. Garcia-Consuegra, R. Merino, I. Calvo, J.J. Garcia, N. Ruperto, and et al. The European Spanish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) Clin Exp Rheumatol 19 2001 S141 S145